MedDeviceSupplyChain.com
Home | About Us | Contact Us | Events | Search | Member Area
 INSPECTIONS
How to Prepare for Inspections
Outside US Inspections
Qualified Third Parties
US Inspections
 ENFORCEMENT ACTIONS
Consent Decrees
Form 483s
Form 483s News
Recalls News
Warning Letters
Warning Letters News
 CAPA
CAPA Essentials
CAPA News
 COMPONENT QUALITY
Adulteration
Counterfeiting
 DISTRIBUTION
Storage
Tracking
Unique Device Identification
 IMPORT CONTROL
US Import Screening
 INFORMATION TECHNOLOGY
Data Management
Data Sharing
 MANUFACTURING
Auditing
GMPs
Outsourcing
Raw Materials
 REGULATIONS/ GUIDANCES/ LEGISLATION
EU
IMDRF/GHTF
ICH
US Regulations
US Regulations News
Other Countries
 RISK MANAGEMENT
Product Liability
Risk Assessments
 SECURITY AND THEFT
Theft
EU Security Efforts
Non-US Countries
US Security Efforts
 SUPPLIER RELATIONS
Acquisitions
Contracts and Agreements
Purchasing Controls
Qualification
Selection and Certification
Home | EU

EU REGULATIONS
Devicemakers Must 'Act Now' on Objections to EU Device Regulations
Devicemakers Must 'Act Now' on Objections to EU Device Regulations Devicemakers that want their voices heard as the European Parliament considers reforms to medical device regulation need to speak up immediately, experts urge. The possibility of approval delays if a proposed premarket review system is adopted is likely to be one of Parliament's biggest qualms. . . . more
EU May Implement Device Directives Sooner Than Planned, Industry Warned
EU May Implement Device Directives Sooner Than Planned, Industry Warned Manufacturers should brace for changes to European device regulations to be completed far sooner than the 2021 now indicated in official plans, experts indicated Wednesday at the MedCon 2013 meeting here. Paul Brooks, president of notified body BSI Product Services, said there are now significant lobbying efforts to start the transition in 2014. The length of the transition period is currently under debate as well, said Brooks, but could be as short as 18 months for the device regulation and 30 months for the in vitro diagnostic device regulation. . . . more
Fewer EU Notified Bodies Could Cost Manufacturers Thousands
A proposed plan to shrink the number of EU notified bodies could cost international devicemakers approximately $100,000 per manufacturing site, one expert says. "If you have a notified body, what happens when it is not on the list?" said Elizabeth George, vice president of global regulations and standards for Philips Healthcare. The European Commission is discussing consolidating the number of notified bodies from 78 to 25 or even 15, said Jürgen Stettin, CEO of Prosystem AG International Healthcare Consulting. . . . more
Industry Keeps Up Pressure Against Centralized EU Authorization
Industry Keeps Up Pressure Against Centralized EU Authorization European devicemakers made clear their opposition to a centralized authorization system for high-risk medical devices during a recent public workshop, saying it would do little to ensure greater safety while delaying patient access to life-saving new technologies. The workshop, hosted by the European Parliament's Environment, Public Health and Food Safety Committee, was intended to gather feedback on the European Commission's proposed device regulations. . . . more
Real-Time Release Testing, Process Validation Tackled in EU Guidelines
Drugmakers may now use real-time release testing (RTRT) instead of end-product testing to demonstrate product quality for additional assessments and are no longer limited to using it for sterility testing, according to a final European Medicines Agency (EMA) guideline. . . . more
EMA Draft Guideline on Process Validation, March 2012
EMA Draft Guideline on Process Validation, March 2012 . . . more
EMA Guideline on Real Time Release Testing, March 2012
EMA Guideline on Real Time Release Testing, March 2012 . . . more
EU Proposes Centralized Expert Group to Oversee Medical Devices
A group of medical device experts from EU member states would oversee device regulation in the union, according to one proposal in a recent “roadmap” released by the European Commission’s Directorate-General for Health & Consumers. . . . more
EMA: GMP Requirements for Qualified Persons, Batch Release Outdated
The European Medicines Agency (EMA) plans to clarify qualified persons' (QPs) responsibilities during batch release when the QP is not at the manufacturing site. . . . more
EU Falsified Medicines Directive, June 2011
EU Falsified Medicines Directive, June 2011 . . . more
EU Directive 2003-94-EC GMP Pharma GMP Directive
EU Directive 2003-94-EC GMP Pharma GMP Directive . . . more